Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer.

Anticancer research - 1 Sept 2012

Maae Else, Andersen Rikke Fredslund, Steffensen Karina Dahl, Jakobsen Erik Hugger, Brandslund Ivan, Sørensen Flemming Brandt, Jakobsen Anders

Abstract excerpt

BACKGROUND: Vascular endothelial growth factor A (VEGFA) is essential in tumour angiogenesis, and polymorphisms in the VEGFA gene have been associated with breast cancer prognosis. The human epidermal growth factor receptor 2 (HER2) is overexpressed in breast tumours and is also associated with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Cyclophosphamide
Share to Docetaxel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epirubicin

Share to Fluorouracil

Share to Receptor, ErbB-2

Share to Taxoids

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 22993299

Genes

VEGFA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22993299-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer.PMID 22993299Read ↗

Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.Semantic proximity Read ↗

Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.Semantic proximity Read ↗

The role of vascular endothelial growth factor a polymorphisms in breast cancer.Semantic proximity Read ↗

VEGFA gene variants are associated with breast cancer progression.Semantic proximity Read ↗

Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer.Semantic proximity Read ↗

Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study.Semantic proximity Read ↗

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.Semantic proximity Read ↗

Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.Semantic proximity Read ↗

Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity.Semantic proximity Read ↗

A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.Semantic proximity Read ↗

Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.Semantic proximity Read ↗

Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.